|
Volumn 209, Issue 4, 2004, Pages 335-337
|
Sclerosing cholangitis and liver transplantation in Langerhans cell histiocytosis: A 14-year follow-up
|
Author keywords
Langerhans cell histiocytosis; Liver transplantation; Sclerosing cholangitis
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
ADULT;
ANAMNESIS;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
CORTICOSTEROID THERAPY;
DIAGNOSTIC APPROACH ROUTE;
DIAGNOSTIC IMAGING;
DIAGNOSTIC TEST;
DISEASE COURSE;
DRUG DOSE REDUCTION;
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;
FEMALE;
GRAFT REJECTION;
HISTIOCYTOSIS X;
HISTOPATHOLOGY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LABORATORY TEST;
LANGERHANS CELL;
LIVER GRAFT;
MEDICAL EXAMINATION;
NEPHROGENIC DIABETES INSIPIDUS;
PRIORITY JOURNAL;
SCLEROSING CHOLANGITIS;
SKIN BIOPSY;
SKULL RADIOGRAPHY;
TISSUE SECTION;
TREATMENT OUTCOME;
ADULT;
BIOPSY, NEEDLE;
CHOLANGITIS, SCLEROSING;
FEMALE;
FOLLOW-UP STUDIES;
HISTIOCYTOSIS, LANGERHANS-CELL;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LIVER FAILURE, ACUTE;
LIVER TRANSPLANTATION;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 8344284402
PISSN: 10188665
EISSN: None
Source Type: Journal
DOI: 10.1159/000080864 Document Type: Article |
Times cited : (17)
|
References (10)
|